Evidence map›Paper›PMID 11956287›Full record

ArticleThe Journal of experimental medicine2002

Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells.

Jian-Xin Gao, Huiming Zhang, Xue-Feng Bai, Jing Wen, Xincheng Zheng, Jinqing Liu, Pan Zheng, Yang Liu

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. The CD8α-PILRα interaction maintains CD8Science (New York, N.Y.) · 2022
    Article
  3. Unregulated antigen-presenting cell activation by T cells breaks self tolerance.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. B7 blockade alters the balance between regulatory T cells and tumor-reactive T cells for immunotherapy of cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009
    Article
  12. FoxP3: a life beyond regulatory T cells.International journal of clinical and experimental pathology · 2009
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jian-Xin GaoDepartment of Pathology and Comprehensive Cancer Center, Division of Cancer Immunology, Ohio State University Medical Center, Columbus, OH 43210, USA.
Huiming Zhang
Xue-Feng Bai
Jing Wen
Xincheng Zheng
Jinqing Liu
Pan Zheng
Yang Liu
The Ohio State University Wexner Medical Center · US

Funding

Tumor burden and T cell immunityR01CA058033 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIU, YANG · 1992 to 2013
$3.3M
RECEPTORS FOR B7-MEDIATED T CELL EFFECTOR FUNCTIONSR01CA069091 · NCI · OHIO STATE UNIVERSITY · PI LIU, YANG · 1996 to 2003
$1.3M
PROTO ONCOGENE PML AND TUMOR EVASION OF HOST IMMUNITYR01CA082355 · NCI · OHIO STATE UNIVERSITY · PI ZHENG, PAN · 1999 to 2002
$657k
HEAT STABLE ANTIGEN, T-CELL RESPONSE, AND TOLERANCER01AI032981 · NIAID · OHIO STATE UNIVERSITY · PI LIU, YANG · 1994 to 2001
$436k
NCI NIH HHS CA58033NCI NIH HHS CA69091NCI NIH HHS CA82355NCI NIH HHS R01 CA058033NIAID NIH HHS AI32981
6 · The paper itself

Abstract

A number of in vitro studies have suggested that costimulatory molecules B7-1 and B7-2 and their receptor CD28 can promote clonal deletion, and limited in vivo studies have indicated that CD28 is involved in the clonal deletion of some T cells. However, the significance of B7-mediated clonal deletion in preventing autoimmune diseases has not been studied systematically. Here we report that the perinatal blockade of B7-1 and B7-2 substantially inhibits the clonal deletion of T cells in the thymus and leads to an accumulation of T cells capable of inducing fatal multiorgan inflammation. These results reveal a critical role for costimulatory molecules B7-1 and B7-2 in deleting pathogenic autoreactive T cells in the thymus. The critical role of B7-1 and B7-2 in T cell clonal deletion may explain, at least in part, the paradoxical increase of autoimmune disease in mice deficient for this family of costimulatory molecules, such as cytotoxic T lymphocyte associated molecule 4, CD28, and B7-2. The strong pathogenicity of the self-reactive T cells supports a central hypothesis in immunology, which is that clonal deletion plays an important role in preventing autoimmune diseases.

Indexed as

AnimalsAntigens, CDAntigens, NeoplasmAntigens, ViralB7-1 AntigenB7-2 AntigenCD4-CD8 RatioCD4 Lymphocyte CountCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesClonal DeletionCytokinesFemaleIntestinesLungMembrane GlycoproteinsAntigens, CDAntigens, NeoplasmAntigens, ViralB7-1 AntigenB7-2 AntigenCd86 protein, mouseCytokinesMembrane GlycoproteinsMtv-7 superantigen, Mouse mammary tumor virustumor rejection antigen P815A, mouse

Identifiers

PMID11956287
PMCPMC2193695
OpenAlexW2127812713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.